Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2025 04:00 ET | Source: AKAMPION

Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas

Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging clinical activity in heavily pre-treated patients including meaningful...
December 04, 2024 04:00 ET | Source: AKAMPION

Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001

Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to ﬁnal dose level 3 Munich, Germany – December 4, 2024 – Thermosome, a drug development company...
November 19, 2024 04:00 ET | Source: AKAMPION

Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 Munich,...